Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer (NCT02688517)
Targeted Genomic Analysis of Human Cancers
🩺 Plain-English Summary (8th-Grade Level)
This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.
Who can join: Review the eligibility criteria below.
Location: Ocean Medical Center — Brick, New Jersey
Age range: 1 Year
🧪 Interventions in This Study
- Cytology Specimen Collection Procedure (OTHER)
- Laboratory Biomarker Analysis (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Ocean Medical Center — Brick, New Jersey
- Bayshore Community Hospital — Holmdel, New Jersey
- RWJBarnabas Health - Jersey City Medical Center, Jersey City — Jersey City, New Jersey
- Southern Ocean County Medical Center — Manahawkin, New Jersey
- Morristown Medical Center — Morristown, New Jersey
- Jersey Shore Medical Center — Neptune City, New Jersey
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
- Riverview Medical Center/Booker Cancer Center — Red Bank, New Jersey
- Riverview Medical Center — Red Bank, New Jersey
- Overlook Hospital — Summit, New Jersey
- University of Wisconsin Hospital and Clinics — Madison, Wisconsin
📞 Contact the Study Coordinator
Phone: (732) 235-2465
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Neoplasm
- Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment — Duarte, California
- Reproductive Health Program in Patients With Cancer — Jonesboro, Arkansas
- rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy — Houston, Texas
- Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — Newark, Delaware
- Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families — Houston, Texas
- Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies — Los Angeles, California
Explore by condition: All Malignant Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.